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Introduction/Background: 
The traditional translation pathway of ‘bench- to-bedside’ will not be enough to integrate 
genomics into routine clinical care. It requires the use of validated and systematic 
‘implementation science’ methods. Within the pipeline of evidence-based translation of 
new technologies, implementation science is the phase that informs policy regarding the 
appropriateness, adoption, feasibility, acceptability, fidelity, penetration, and sustainability 
of technologies being transferred from research settings into the real world. Without 
implementation science, barriers can emerge unchecked and key drivers neglected. 
Health services researchers now have a large knowledge base which identifies barriers 
and drivers for implementation of new technologies into healthcare.  
 
 
Research Question: 
How is ‘implementation science’ incorporated into the National Health Genomics Policy 
Framework?  
 
 
 
Methodology: 
Inductive analysis was used to identify the explicit and implicit use of implementation 
science outcomes within the National Health Genomics Policy Framework and the 
Supplementary Information documents.  
 
Findings: 
No explicit identification or use of ‘implementation science’ as a translational research 
phase required for building an evidence base that will be essential to guiding policy 
formation. We identified three out of five ‘Strategic Priority Areas’ as requiring 
implementation science research to integrate genomics into real-world settings with no 
mention of implementation science methods. The word ‘implementation’ was used only to 
describe the high-level execution of the national policy which has been planned as the 
next framework. However, the framework did incorporate implementation science 
outcomes such as ‘uptake’ and the identification of some barriers and facilitators for the 
‘uptake’ of genomics into Australian healthcare. 
 
Policy Implications: 
When creating the implementation plan for the National Health Genomics Policy 
Framework, it is essential to explicitly include implementation science as part of the 
research translation pipeline and utilise it as a tool to accomplish the ‘Strategic Priority 
Areas’ identified within the framework.  
 
 
 
N.B. All presenters will be asked to include a final slide in their presentations that 
summarises the policy recommendations and/or implications that can be drawn 
from the research presented. 
 
 
